Clinical Trial

SpaceIT Hydrogel System for Perirectal Spacing

Study acronym: HYDROSPACE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.
Protocol Amendment History 4 changes
notable Primary completion pushed: 2026-07-30 -> 2026-08-30 2026-08-13
notable Primary completion pushed: 2026-06-30 -> 2026-07-30 2026-07-17
notable Trial sites reduced: 29 -> 26 locations 2026-05-13
notable Primary completion pushed: 2026-03-31 -> 2026-06-30 2026-04-17
Trial Details
NCT Number NCT06451614
Lead Sponsor Boston Scientific Corporation
Conditions Prostate Cancer
Enrollment 230 participants
Start Date 2024-10-30
Primary Completion 2026-08-30 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12